Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12168060rdf:typepubmed:Citationlld:pubmed
pubmed-article:12168060lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:12168060lifeskim:mentionsumls-concept:C0006141lld:lifeskim
pubmed-article:12168060lifeskim:mentionsumls-concept:C0206364lld:lifeskim
pubmed-article:12168060lifeskim:mentionsumls-concept:C1171362lld:lifeskim
pubmed-article:12168060lifeskim:mentionsumls-concept:C0907649lld:lifeskim
pubmed-article:12168060lifeskim:mentionsumls-concept:C0596263lld:lifeskim
pubmed-article:12168060lifeskim:mentionsumls-concept:C1517945lld:lifeskim
pubmed-article:12168060pubmed:issue5lld:pubmed
pubmed-article:12168060pubmed:dateCreated2002-8-8lld:pubmed
pubmed-article:12168060pubmed:abstractTextMembers of the Eph family of receptor tyrosine kinase have been implicated in cell-cell communication and tissue integrity during embryogenesis. We have previously demonstrated cell type specific and hormone dependent EphB4 expression in the mouse mammary parenchyma suggesting involvement in the homeostasis of this organ. Since disruption of tissue organization is crucial for metastatic dissemination, we have investigated the expression of EphB4 during carcinogenesis of the human breast. Immunohistochemical analysis of 24 normal human breast samples and 124 consecutive breast carcinomas was correlated with tumor characteristics (stage, histology, grade, lymph node involvement) and the expression of ER, PR, Ki-67, p53 and HER2. In normal breast tissue, the EphB4 protein was expressed exclusively in parenchymal cells. Strikingly, a drastic reduction in the number of EphB4 protein expressing cells was observed in almost all invasive carcinomas analyzed, irrespective of the tumor type (p<0.0001). Furthermore, we found a highly significant correlation between EphB4 positivity and low histological grading of the tumor cells (p=0.002) suggesting that in breast cancer, EphB4 expression is not compatible with tumor progression. This raises the possibility that EphB4 could represent a potent tool for therapeutic intervention.lld:pubmed
pubmed-article:12168060pubmed:languageenglld:pubmed
pubmed-article:12168060pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12168060pubmed:citationSubsetIMlld:pubmed
pubmed-article:12168060pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12168060pubmed:statusMEDLINElld:pubmed
pubmed-article:12168060pubmed:issn1021-335Xlld:pubmed
pubmed-article:12168060pubmed:authorpubmed-author:RohrbachValer...lld:pubmed
pubmed-article:12168060pubmed:authorpubmed-author:AndresAnne-Ca...lld:pubmed
pubmed-article:12168060pubmed:authorpubmed-author:ZiemieckiAndr...lld:pubmed
pubmed-article:12168060pubmed:authorpubmed-author:DjonovValenti...lld:pubmed
pubmed-article:12168060pubmed:authorpubmed-author:BerclazGilles...lld:pubmed
pubmed-article:12168060pubmed:authorpubmed-author:DreherEkkehar...lld:pubmed
pubmed-article:12168060pubmed:authorpubmed-author:AltermattHans...lld:pubmed
pubmed-article:12168060pubmed:authorpubmed-author:FlütschBettin...lld:pubmed
pubmed-article:12168060pubmed:issnTypePrintlld:pubmed
pubmed-article:12168060pubmed:volume9lld:pubmed
pubmed-article:12168060pubmed:ownerNLMlld:pubmed
pubmed-article:12168060pubmed:authorsCompleteYlld:pubmed
pubmed-article:12168060pubmed:pagination985-9lld:pubmed
pubmed-article:12168060pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:12168060pubmed:meshHeadingpubmed-meshheading:12168060...lld:pubmed
pubmed-article:12168060pubmed:meshHeadingpubmed-meshheading:12168060...lld:pubmed
pubmed-article:12168060pubmed:meshHeadingpubmed-meshheading:12168060...lld:pubmed
pubmed-article:12168060pubmed:meshHeadingpubmed-meshheading:12168060...lld:pubmed
pubmed-article:12168060pubmed:meshHeadingpubmed-meshheading:12168060...lld:pubmed
pubmed-article:12168060pubmed:meshHeadingpubmed-meshheading:12168060...lld:pubmed
pubmed-article:12168060pubmed:meshHeadingpubmed-meshheading:12168060...lld:pubmed
pubmed-article:12168060pubmed:meshHeadingpubmed-meshheading:12168060...lld:pubmed
pubmed-article:12168060pubmed:articleTitleLoss of EphB4 receptor tyrosine kinase protein expression during carcinogenesis of the human breast.lld:pubmed
pubmed-article:12168060pubmed:affiliationDepartment of Obstetrics and Gynecology, Univeristy Hospital, Inselspital Berne, Schanzeneckstrasse 1, Switzerland. gilles.berclaz@insel.chlld:pubmed
pubmed-article:12168060pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12168060pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12168060lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12168060lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12168060lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12168060lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12168060lld:pubmed